Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
3.150
+0.610 (24.02%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $33.59 million as of March 23, 2026. Its market cap has decreased by -27.75% in one year.
Market Cap
33.59M
Enterprise Value
27.40M
1-Year Change
-27.75%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $33.59M, a decrease of -73.15%. That is a compound annual growth rate of -48.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 33.97M | 66.54% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 29.16M |
| CEL-SCI | 29.10M |
| Kyntra Bio | 28.85M |
| Tiziana Life Sciences | 28.76M |
| Exicure | 28.36M |
| PDS Biotechnology | 27.97M |
| Boundless Bio | 26.66M |
| IGC Pharma | 26.58M |